Reports
Sale
Global Nanomedicine Market Size, Price, Analysis: By Product Type: Therapeutics, Regenerative Medicine, Vaccines, Others; By Type: Nanoparticles, Nano shells, Nano Devices, Others; By Modality: Diagnostic, Treatment; By Indications: Drug Delivery, Diagnostic Imaging, Tissue Regeneration, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Nanomedicine Market Outlook
The global nanomedicine market size attained a value of USD 239.1 billion in 2023. The market is anticipated to grow at a CAGR of 11.6% during the forecast period of 2024-2032 to attain a value of USD 677.7 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Demand for Nanomedicines to Augment the Market Growth
The increase in the demand for nanomedicines can be attributed to the rapidly increasing applications of nanomaterials like nanocapsules as well as nanotubes in drug delivery systems. The demand for nanomedicines is further aided by the increase in the incidences of cancer and cardiovascular diseases, leading to the growth of public and private investments in nanomedicine research and advancements in biodegradable nanoparticles. The cost-effectiveness and fewer side-effects of these therapies are also major drivers of the nanomedicine industry growth.
North America to be a Significant Regional Market for Nanomedicine with the Asia Pacific Being One of the Fastest Growing Markets
Due to substantial government spending on nanomedicine research in the United States, the North American nanomedicine industry is expected to be one of the leading markets for nanomedicine in the forecast period of 2024-2032. The increased availability of patented nanomedicine items is credited with the region's growth. In addition to a well-developed healthcare infrastructure and a significant incidence of cancer, nanomedicine is easily accessible in this region, which has aided the market growth further.
The large geriatric population in the Asia Pacific is witnessing high incidence rates of cancer and cardiovascular diseases, which is expected to boost the nanomedicine market in the region. The regional market is expected to be one of the fastest growing markets for nanomedicine. The market growth in the Asia Pacific is expected to be aided by the increase in research grants to tackle life-threatening diseases, with countries like China and Japan leading the way.
Nanomedicine: Market Segmentation
Nanomedicine is a segment of nanotechnology that is used to diagnose, treat, monitor, and regulate biological systems. It improves medicine delivery by manipulating materials at the nanoscale. As a result, nanomedicine has aided in the treatment of a variety of illnesses. Nanomedicine is still in its infancy, with numerous items under development. Nanobiotix has identified 230 nanomedicine products that are either marked or in the trial phase. Out of the 230 products, 49 are in the market, and 122 are in the clinical trial phases, either in Phase II or Phase III trials.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on product type, the market can be segmented into:
- Therapeutics
- Regenerative Medicine
- In-Vitro Diagnostics
- In-Vivo Diagnostics
- Vaccines
By application, the market is categorised into:
- Clinical Oncology
- Infectious Diseases
- Clinical Cardiology
- Orthopaedics
- Others
On the basis of nanomolecule type, the industry is categorised into:
- Nanoparticles and Quantum Dots
- Metal and Metal Compounds
- Liposomes
- Polymer and Polymer Drug Conjugate
- Hydrogel Nanoparticles
- Dendrimers
- Inorganic Nanoparticles
- Nanoshells
- Nanotubes
- Nanodevices
The major regional markets of nanomedicine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Focus on Technological Advancements for Improved Healthcare Services to Bolster the Growth of the Nanomedicine Industry
Currently, the healthcare sector is one of the most important areas where nanotechnology has made significant progress in the detection and treatment of chronic diseases such as cancer, heart disease, and other disorders. Firms researching patch technologies have attracted significant financing as healthcare companies focus on transdermal insulin administration as the industry's emphasis is moving toward transdermal medication delivery. Further, the tailored medication delivery method is being emphasised heavily in order to reduce the risk of side effects. Bypassing the body's defence mechanisms, this method provides reachability with increased efficacy and minimum degradation. Such technological developments and investments are likely to propel the growth of the market in the coming years.
Key Industry Players in the Global Nanomedicine Market
The report gives a detailed analysis of the following key players in the global nanomedicine market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Arrowhead Pharmaceuticals, Inc.
- Nanospectra Biosciences, Inc.
- Ablynx N.V.
- AMAG Pharmaceuticals, Inc.
- Celgene Corporation
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Type |
|
| Breakup by Modality |
|
| Breakup by Indications |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nanomedicine Market Overview
3.1 Global Nanomedicine Market Historical Value (2017-2023)
3.2 Global Nanomedicine Market Forecast Value (2024-2032)
4 Global Nanomedicine Market Landscape
4.1 Global Nanomedicine Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Nanomedicine Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Modality
4.2.3 Analysis by Indications
5 Global Nanomedicine Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Nanomedicine Market Segmentation
6.1 Global Nanomedicine Market by Product Type
6.1.1 Market Overview
6.1.2 Therapeutics
6.1.3 Regenerative Medicine
6.1.4 Vaccines
6.1.5 Others
6.2 Global Nanomedicine Market by Type
6.2.1 Market Overview
6.2.2 Nanoparticles
6.2.2.1 Gold Nanoparticles
6.2.2.2 Iron Oxide Nanoparticles
6.2.2.3 Hydrogel Nanoparticles
6.2.2.4 Others
6.2.3 Nano shells
6.2.4 Nano Devices
6.2.5 Others
6.3 Global Nanomedicine Market by Modality
6.3.1 Market Overview
6.3.2 Diagnostic
6.3.3 Treatment
6.4 Global Nanomedicine Market by Indications
6.4.1 Market Overview
6.4.2 Drug Delivery
6.4.3 Diagnostic Imaging
6.4.4 Tissue Regeneration
6.4.5 Infectious Disease
6.4.6 Orthopedics
6.4.7 Neurological disease
6.4.8 Oncology
6.4.9 Others
6.5 Global Nanomedicine s Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Nanomedicine Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Nanomedicine Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Nanomedicine Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Nanomedicine Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Nanomedicine Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Invitae Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 General Electric Company
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Leadiant Biosciences, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Johnson & Johnson Services, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Mallinckrodt
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Merck Sharp & Dohme Corp.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Nanosphere Health Sciences, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Pfizer Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Celgene Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Teva Pharmaceutical Industries Ltd.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Gilead Sciences, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Amgen Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Bristol-Myers Squibb Company
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Abbvie Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Novartis AG
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 F. Hoffmann-La Roche Ltd
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 Luminex Corporation
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Lilly
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 Nanobiotix
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
17.21 Sanofi
17.21.1 Financial Analysis
17.21.2 Product Portfolio
17.21.3 Demographic Reach and Achievements
17.21.4 Mergers and Acquisitions
17.21.5 Certifications
18 Global Nanomedicine Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The nanomedicine market was valued at USD 239.1 billion in 2023.
The market is expected to grow at a CAGR of 11.6% from 2024 to 2032 to reach a value of USD 677.7 billion by 2032.
The major drivers of the industry, such as emerging technologies for drug delivery, increase in adoption of nanomedicine across varied applications, rise in government support and funding, growth in the need for therapies with fewer side effects, and cost-effectiveness of therapies, are expected to aid the market growth.
The key market trends guiding the growth of the industry include out-licensing of nanodrugs and growth of the healthcare facilities.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading product types of nanomedicine in the industry are therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines.
The major application segment in the market are clinical oncology, infectious diseases, clinical cardiology, and orthopaedics, among others.
The significant nanomolecule types in the industry are nanoparticles and quantum dots, nanoshells, nanotubes, and nanodevices.
The major players in the industry are Arrowhead Pharmaceuticals, Inc., Nanospectra Biosciences, Inc., Ablynx N.V., AMAG Pharmaceuticals, Inc., and Celgene Corporation, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER